Ofatumumab With Ivac for DLBCL Patients Who Failed R-Chop and Were Not Candidates for High-Dose Therapy and Asct - Phase 2 Trial of the Polish Lymphoma Research Group (Plrg-8)

Hematological Oncology - United Kingdom
doi 10.1002/hon.111_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

First‐line R‐CVP Versus R‐CHOP Induction Immunochemotherapy for Indolent Lymphoma With Rituximab Maintenance. A Multicentre, Phase III Randomized Study by the Polish Lymphoma Research Group PLRG4

British Journal of Haematology
Hematology
2019English

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Global Pivotal Phase 2 Trial of the Cd19-Targeted Therapy Ctl019 in Adult Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (Dlbcl)-An Interim Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Phase II Study of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

British Journal of Haematology
Hematology
2017English

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy